Wistar Institute scientists have designed a two-vaccine approach that not only targets the tumors’ unique molecular identity ...

The Las Vegas Desert Dogs host their annual Tucker Out Lymphoma game, honoring Tucker Williams while raising awareness and support for pediatric cancer research. #PaidForContent ...

T cell lymphomas are notoriously difficult to treat because immunotherapy, despite being one of the most effective therapies for treating cancer, can't easily distinguish cancerous T cells from ...

Glo-BNHL global trial opens sites in Netherlands and Austria to trial multiple new treatments for B-cell Non-Hodgkin Lymphoma ...

Debi Weiss thought her fatigue and weakness was a seasonal illness, but her condition quickly worsened.

One moment changed Lonetta Bradford’s life forever.

A team of Santa Barbara high school students leading a fundraising campaign for Blood Cancer United will host a community fundraiser Wednesday, March 18 ...

Ipsen telegraphed plans to acquire Epizyme and the FDA-approved Tazverik in June 2022, two years after the med’s clearance in the U.S. as both an epithelioid sarcoma and follicular lymphoma treatment.

“[I thought] I had an intolerance to vodka," said Claire Dougherty ...

Dr Alison Oliver has spoken out after a lifeline drug has been blocked by health bosses.

LONDON, March 10, 2026 /PRNewswire/ -- The "Checkpoint Inhibitor Refractory Cancer Drugs Market -- Growth, Share, Opportunities & Competitive Analysis, 2025 -- 2032" report has been added to the ...

Confirmatory trial on tazemetostat suggested a link with secondary hematologic malignancie ...